Novartis Ag (NVS) Inventory Average (2018 - 2025)
Novartis Ag's Inventory Average history spans 8 years, with the latest figure at $6.0 billion for Q4 2025.
- For Q4 2025, Inventory Average rose 3.06% year-over-year to $6.0 billion; the TTM value through Dec 2025 reached $6.0 billion, up 3.06%, while the annual FY2025 figure was $6.0 billion, 3.06% up from the prior year.
- Inventory Average for Q4 2025 was $6.0 billion at Novartis Ag, up from $5.8 billion in the prior quarter.
- Across five years, Inventory Average topped out at $6.9 billion in Q4 2022 and bottomed at $5.8 billion in Q4 2024.
- The 5-year median for Inventory Average is $6.5 billion (2023), against an average of $6.4 billion.
- The largest annual shift saw Inventory Average increased 5.22% in 2021 before it fell 11.09% in 2024.
- A 5-year view of Inventory Average shows it stood at $6.9 billion in 2021, then grew by 0.32% to $6.9 billion in 2022, then decreased by 5.44% to $6.5 billion in 2023, then dropped by 11.09% to $5.8 billion in 2024, then rose by 3.06% to $6.0 billion in 2025.
- Per Business Quant, the three most recent readings for NVS's Inventory Average are $6.0 billion (Q4 2025), $5.8 billion (Q4 2024), and $6.5 billion (Q4 2023).